People

Sofia Pacheco

Vice president leading strategy and portfolio development at NewVale Capital. She previously spent nearly a decade at Alexion, including during its AstraZeneca acquisition, working on business development and transactions in rare and specialty diseases. Earlier she led strategic planning at BioChemics. She holds Stanford economics and Babson MBA degrees.